This study aims to assess the association of piperacillin/tazobactam and meropenem minimum inhibitory concentration (MIC) and beta-lactam resistance genes with mortality in the MERINO trial.

Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study

Falcone, M;
2020-01-01

Abstract

This study aims to assess the association of piperacillin/tazobactam and meropenem minimum inhibitory concentration (MIC) and beta-lactam resistance genes with mortality in the MERINO trial.
2020
Henderson, A; Paterson, D L; Chatfield, M D; Tambyah, P A; Lye, D C; De, P P; Lin, R T P; Chew, K L; Yin, M; Lee, T H; Yilmaz, M; Cakmak, R; Alenazi, T H; Arabi, Y M; Falcone, M; Bassetti, M; Righi, E; Ba, Rogers; Kanj, S S; Bhally, H; Iredell, J; Mendelson, M; Boyles, T H; Looke, D F M; Runnegar, N J; Miyakis, S; Walls, G; Ai Khamis, M; Zikri, A; Crowe, A; Ingram, P R; Daneman, N N; Griffin, P; Athan, E; Roberts, L; Beatson, S A; Peleg, A Y; Cottrell, K K; Bauer, M J; Tan, E; Chaw, K; Nimmo, G R; Harris-Brown, T; Harris, P N A
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1071250
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact